Watch now - Mastering IVDR in 2025: Challenges and Strategies Across the Full Compliance Spectrum
The In Vitro Diagnostic Regulation (IVDR) represents one of the most significant regulatory shifts in the EU for IVD manufacturers, and the changes coming into force in 2025 are especially critical.
With the end of key transition periods, manufacturers must now comply with stricter requirements around risk classification, clinical evidence, post-market surveillance and technical documentation.
Webinar date: Sept. 30, 2025
Speaker: Anais Larry, IVDR Program Manager, Consumer Medical and Information Technologies, UL Solutions
You will learn about:
- Legacy Devices & Transition Periods (2025–2027) - How to manage extensions, maintain market access and keep your documentation audit-ready.
- Performance Evaluation & Clinical Evidence - How to handle legacy data, justify equivalence and know when a clinical performance study is truly needed.
- Risk Classification Challenges - Real-world examples of tricky classifications—like genetic tests and companion diagnostics—and how to navigate the gray zones.
- AI in IVDs - How machine learning is being regulated under IVDR, what performance evaluation looks like for AI-based diagnostics and how the EU AI Act fits into the picture.
Attend an upcoming webinar
Ready to elevate your industry IQ with insights and news from experts? Register for one of our upcoming events.
Get connected with our team
Thanks for your interest in our products and services. Let's collect some information so we can connect you with the right person.